Answers are grounded in this paper and cite their sources.
Traditional two-dimensional cell culture and animal models cannot faithfully recapitulate human liver physiology and drug responses due to oversimplified tissue architecture and inherent species discrepancies. Three-dimensional liver organoids represent a promising humanized platform to mimic native hepatic features in vitro. Current liver organoid systems are largely maintained under static culture, lacking physiological fluid circulation and intact hepatic sinusoidal microenvironments, resulting in insufficient cellular maturation and inconsistent experimental outputs. Most existing models do not incorporate liver sinusoidal endothelial cells, restricting the reconstruction of physiological cell-to-cell crosstalk in liver tissue. In this work, we established a standardized co-culture system for human liver organoids, which reconstructed biomimetic hepatic sinusoidal microenvironments and enhanced organoid maturation and experimental stability. This system provides a feasible pre-clinical tool for liver-disease research and hepatotoxicity drug screening. Nevertheless, the model is limited by the absence of immune components and incomplete hepatic functional maturation. Future studies may optimize multi-cell co-culture schemes and long-term differentiation protocols to advance biomimicry and promote the application of liver organoids in precision medicine and high-throughput drug developmen.
No takes yet. Share an insight, caveat, or question.
Yiheng Gao (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: